Stockreport

Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com
PDF -- Anticipate global AYVAKIT net product revenue of approximately $360 million to $390 million in 2024, representing 80 percent year-over-year growth at the midpoint -- [Read more]